Saliva study for MuSK myasthenia gravis
Part of Brain & nervous system, Cancer, Immune system & allergy clinical trials.
This study gathers saliva samples from people with MuSK myasthenia gravis to better understand the condition. Participation involves providing a saliva sample and sharing your lab results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a lab test confirming a diagnosis of MuSK myasthenia gravis.
- You must be willing to provide a saliva sample, either by mail or in person.
- You must be willing to share your lab results showing elevated muscle-specific kinase antibodies.
- You must be able to give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental oral medication called NMD670 for people with myasthenia gravis (MG). It aims to see if the drug is safe and if it helps improve muscle strength and daily function.
This study follows people with suspected or confirmed myasthenia gravis (a condition that causes muscle weakness that gets worse with use). It uses several specialized nerve and antibody tests to make a more precise diagnosis and tracks you over time to see how well these methods work.
This study creates a registry to collect information about people with myasthenia gravis in China. By joining, you help researchers learn more about the condition and how it affects different people.
This study uses your smartphone to record symptoms like slurred speech, hoarseness, arm fatigue, or droopy eyelids, making it easier for doctors to understand and monitor myasthenia gravis. Both people with MG and healthy volunteers can take part.
This study uses digital tools like questionnaires and smartphone tests to measure how myasthenia gravis affects you. It aims to create a better way for doctors to track your symptoms and adjust treatment.
This trial is a global registry for people with myasthenia gravis (MG). It collects information to help researchers better understand MG and improve care.
Hear when a new Myasthenia Gravis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.